Clinical Trials Browser

NCT03445858 2026-02-18

Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults

Phase EARLY_PHASE1 Completed

22 enrolled

Lymphoid

Lymphoma, Neoplasms, Recurrence

NCT07337785 2026-01-22

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Phase EARLY_PHASE1 Recruiting

36 enrolled

Multiple Sclerosis, Myasthenia Gravis, Recurrence, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Clinical Trials

Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Clinical Study of LV009 Injection in the Treatment of Recurrent/Refractory CD19 Positive Blood Tumors

AB154 Combined With AB122 for Recurrent Glioblastoma

Safety and Efficacy of ZZSW-01 in Relapsed/Refractory B-cell Malignancies

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas

CAR19BCMA

CD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)

High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed

A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy

Pilot Trial for Treatment of Recurrent Glioblastoma